Reelart 5 mg (Tablet)
Medicine Details
| Category | Details |
|---|---|
| Generic | Desloratadine |
| Company | Mst pharma |
Indications
Relief of symptoms associated with seasonal and perennial allergic rhinitis and chronic idiopathic urticaria
Symptoms
- Sneezing
- Nasal discharge
- Itching
- Congestion
- Ocular itching
- Tearing
- Redness
- Itching of palate
- Coughing
- Size & number of hives
- Itching relief
Pharmacology
Desloratadine, the major active metabolite of Loratadine, is a non-sedating, long-acting tricyclic histamine antagonist with selective H1-receptor histamine antagonist activity
Dosage & Administration
- Pediatric drops:
- Child 6-11 months: 2 ml drops once daily
- Child 1-2 years: 2.5 ml drops once daily
- Syrup:
- Child 6-11 months: 2 ml once daily
- Child 1-5 years: 2.5 ml once daily
- Child 6-11 years: 5 ml once daily
- Adults & >12 years: 10 ml once daily
- Tablet:
- Adults and children 12 years and over: 1 tablet daily
Interaction
No clinically relevant drug interactions reported
Contraindications
Hypersensitivity to Desloratadine, Loratadine, or any of its ingredients
Side Effects
- Headache
- Nausea
- Fatigue
- Dizziness
- Pharyngitis
- Dyspepsia
- Myalgia
Pregnancy & Lactation
- Pregnancy Category: C
- Use during Pregnancy: Not established unless clearly indicated
- Breastfeeding: Consider discontinuing nursing or Desloratadine based on importance of the drug to the mother
Precautions & Warnings
Starting dose adjustment recommended for adult patients with liver or renal impairment, and those with medical or familial history of seizures
Use in Special Populations
Recommended in children & adolescents
Overdose Effects
No clinically relevant adverse effects reported
Therapeutic Class
Non-sedating antihistamines
Storage Conditions
Store in a cool & dry place, protected from light, below 30°C. Keep all medicines out of the reach of children